Watch the webinar on a risk-based approach to skip-lot testing
In this webinar, you will learn:
• When skip-batch testing can safely be used
• Ongoing monitoring and trend review you should implement to minimize risk
• Real examples from pharmaceutical manufacturers.
• When skip-batch testing can safely be used
• Ongoing monitoring and trend review you should implement to minimize risk
• Real examples from pharmaceutical manufacturers.
Resources
Access the webinar transcript.
Send a question to our technical expert.
Contact our sales team.
Meet the expert speaker
Daniela D Almeida Peres, PhD spent 15 years in research and development at prominent pharmaceutical companies before joining DFE Pharma as technical manager of Latin America. She holds a PhD in Pharmaceutical Production and Control from Universidade de São Paulo.